Comprehensive Cellular Vaccine Immune Monitoring Consortium

The goal of this consortium is to implement a comprehensive program for assessing vaccine-elicited T and B cell responses in humans and nonhuman primates. In the current iteration of the grant we will further expand our testing capabilities by applying cutting-edge technology to the problem of cellular immune monitoring. The CCVIMC will evaluate cellular immune responses induced by vaccines in hopes of identifying immune correlates associated with robust and durable immunity capable of either decreasing or eliminating new infections in vaccines, or controlling virus replication and preventing subsequent transmission. The entire operation will be administratively overseen by the FNIH, and scientifically directed by the consortium PI Richard Koup.

Results & Accomplishments

The Vaccine Immune Monitoring Consortium was first established in 2005 and has been providing high-quality cellular immune monitoring to the Collaboration for AIDS Vaccine Development (CAVD) for more than 10 years.

Data Access

The Collaboration for AIDs Vaccine Discovery: Study Results


Case Western Reserve University
Duke University
Fred Hutchinson Cancer Research Center
National Institute of Allergy and Infectious Diseases
Vaccine Research Center


David Brown, Scientific Program Manager,